Evidence map›Paper›PMID 27554435›Full record

ArticleScientific reports2016

Staphylokinase has distinct modes of interaction with antimicrobial peptides, modulating its plasminogen-activation properties.

Leonard T Nguyen, Hans J Vogel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Gut Virome: Role and Distribution in Health and Gastrointestinal Diseases.Frontiers in cellular and infection microbiology · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Unstable chromosome rearrangements inProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  15. Helical Structure of Recombinant Melittin.The journal of physical chemistry. B · 2019
    Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Leonard T NguyenBiochemistry Research Group, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
Hans J VogelBiochemistry Research Group, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
University of Calgary · CA

Funding

CIHR
6 · The paper itself

Abstract

Staphylokinase (Sak) is a plasminogen activator protein that is secreted by many Staphylococcus aureus strains. Sak also offers protection by binding and inhibiting specific antimicrobial peptides (AMPs). Here, we evaluate Sak as a more general interaction partner for AMPs. Studies with melittin, mCRAMP, tritrpticin and bovine lactoferricin indicate that the truncation of the first ten residues of Sak (SakΔN10), which occurs in vivo and uncovers important residues in a bulge region, improves its affinity for AMPs. Melittin and mCRAMP have a lower affinity for SakΔN10, and in docking studies, they bind to the N-terminal segment and bulge region of SakΔN10. By comparison, lactoferricin and tritrpticin form moderately high affinity 1:1 complexes with SakΔN10 and their cationic residues form several electrostatic interactions with the protein's α-helix. Overall, our work identifies two distinct AMP binding surfaces on SakΔN10 whose occupation would lead to either inhibition or promotion of its plasminogen activating properties.

Indexed as

AnimalsAntimicrobial Cationic PeptidesBinding SitesCathelicidinsCattleLactoferrinMelittenMetalloendopeptidasesModels, MolecularMolecular Docking SimulationOligopeptidesPlasminogenProtein Structure, SecondaryStaphylococcus aureusSubstrate SpecificityAntimicrobial Cationic PeptidesauR protein, Staphylococcus aureusCathelicidinslactoferricin BLactoferrinMelittenMetalloendopeptidasesOligopeptidesPlasminogentritrpticin

Identifiers

PMID27554435
PMCPMC4995489
OpenAlexW2509545693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.